Diabetes and Suppressors of Cytokine Signaling Proteins
- 1 February 2007
- journal article
- review article
- Published by American Diabetes Association in Diabetes
- Vol. 56 (2), 541-548
- https://doi.org/10.2337/db06-1068
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- Regulation of pancreatic -cell mass and proliferation by SOCS-3Journal of Molecular Endocrinology, 2005
- Differences in Suppressor of Cytokine Signaling-1 (SOCS-1) Expressing Islet Allograft Destruction in Normal BALB/c and Spontaneously-Diabetic NOD Recipient MiceTransplantation, 2005
- Molecular and anatomical determinants of central leptin resistanceNature Neuroscience, 2005
- SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2Journal of Biological Chemistry, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- SOCS-1 Protein Prevents Janus Kinase/STAT-dependent Inhibition of β Cell Insulin Gene Transcription and Secretion in Response to Interferon-γPublished by Elsevier BV ,2001
- Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin ReceptorPublished by Elsevier BV ,2001
- LeptinAnnual Review of Physiology, 2000
- The Role of SOCS-3 in Leptin Signaling and Leptin ResistancePublished by Elsevier BV ,1999
- Identification of SOCS-3 as a Potential Mediator of Central Leptin ResistanceMolecular Cell, 1998